Symphony Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Symphony Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,927	Closed	-$224K	–	450
2016 Q3	$224K	Sell	2,927 -1,904	-39%	-$139K	0.02%	378
2016 Q2	$364K	Sell	4,831 -6,268	-56%	-$505K	0.04%	272
2016 Q1	$967K	Sell	11,099 -723	-6%	-$63.3K	0.1%	192
2015 Q4	$1.4M	Buy	11,822 +1,098	+10%	+$109K	0.15%	154
2015 Q3	$944K	Buy	10,724 +8,745	+442%	+$1.02M	0.11%	193
2015 Q2	$215K	Buy	+1,979	New	+$246K	0.03%	386

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Symphony Asset Management's TNDM Position: Q4 2016 in Review

Symphony Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2016, closing a stake of 2,927 shares — an estimated $224K sold.

Symphony Asset Management first reported a position in TNDM in Q2 2015 and held it in 6 quarters. The position peaked at $1.4M in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

Symphony Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2016 after selling out during the quarter.
Symphony Asset Management sold 2,927 Tandem Diabetes Care shares in Q4 2016, an estimated $224K.
Symphony Asset Management first reported a position in Tandem Diabetes Care in Q2 2015 and held it in 6 quarters.
Symphony Asset Management's Tandem Diabetes Care position peaked at $1.4M in Q4 2015.
75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on Symphony Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.